Aaron Cox

Insider Reports History

Entity
Individual
Location
C/O Horizon Therapeutics Plc, 70 St. Stephen's Green, Dublin, Ireland
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aaron Cox:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Horizon Therapeutics Public Ltd Co EVP, Chief Financial Officer Restricted Stock Units (RSU) 23K Jan 4, 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Chief Financial Officer Performance Restricted Stock Units (PSUs) 14K Dec 27, 2022 Direct
Horizon Therapeutics Public Ltd Co EVP, Chief Financial Officer Performance Restricted Stock Units (PSU) 4.65K Dec 30, 2022 Direct
Horizon Therapeutics Public Ltd Co EVP, Chief Financial Officer Ordinary Shares 0 $116.50 Oct 6, 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Chief Financial Officer Performance Restricted Stock Units 0 Oct 6, 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Chief Financial Officer Restricted Stock Units 0 Oct 6, 2023 Direct

Insider Reports Filed by Aaron Cox

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HZNP Horizon Therapeutics Public Ltd Co Oct 6, 2023 13 -$64.8K 4 Oct 6, 2023 EVP, Chief Financial Officer
HZNP Horizon Therapeutics Public Ltd Co Jan 13, 2023 1 -$4.09M 4 Jan 17, 2023 EVP, Chief Financial Officer
HZNP Horizon Therapeutics Public Ltd Co Jan 4, 2023 1 $0 4 Jan 6, 2023 EVP, Chief Financial Officer
HZNP Horizon Therapeutics Public Ltd Co Dec 30, 2022 10 -$3.27M 4 Jan 4, 2023 EVP, Chief Financial Officer
HZNP Horizon Therapeutics Public Ltd Co Dec 27, 2022 4 $0 4 Dec 29, 2022 EVP, Chief Financial Officer
HZNP Horizon Therapeutics Public Ltd Co May 16, 2022 0 $0 3 May 16, 2022 EVP, Chief Financial Officer